News & Insights

pexels-nappy

DATA SHOWS GCT-007 TO BE COMPARABLE TO PAXALISIB IN INITIAL PRE-CLINICAL STUDIES

For Immediate Release Contact: info@globalcancertechnology.com                                                                                                 GLOBAL CANCER TECHNOLOGY REPORTS

pexels-nappy
pexels-nappy

GLOBAL CANCER TECHNOLOGY RECIEVES EURASIAN GRANT OF LICENSED PATENT

For Immediate Release                                                                                                              Contact: info@globalcancertechnology.com GLOBAL CANCER TECHNOLOGY

GLOBAL CANCER TECHNOLOGY EXHIBITS AT THE ‘KUKUNA O KA LA’ RADIATION ONCLOGY CONFERENCE IN KONA

Global Cancer Technology is innovating the treatment of deadly diseases like glioblastoma – it’s not science fiction any more! Scintillating nanoparticles can theoretically be coated in GCT’s cancer inhibitor that is currently being tested in animal models, then be injected into the bloodstream and designed to bind to the tumor’s surface.

pexels-nappy
pexels-nappy
pexels-nappy
pexels-nappy
pexels-nappy
Bob Proulx
cancer treatment nanoparticles

Science Fiction is now True in 2022

Global Cancer Technology is innovating the treatment of deadly diseases like glioblastoma – it’s not science fiction any more! Scintillating nanoparticles can theoretically be coated in GCT’s cancer inhibitor that is currently being tested in animal models, then be injected into the bloodstream and designed to bind to the tumor’s surface.

innovative cancer treatments for patients

The Future of Cancer Treatment Looks Bright

Over the last few months, more than $30 billion has been invested in biotechnology companies to spur research and development, particularly in the area of cancer treatments. Companies like Global Cancer Technology are developing innovative treatments in an effort to one day halt the progression of deadly diseases like glioblastoma.

12/31